ATP Life Science Ventures L.P. 13D/13G Filings for Akero Therapeutics, Inc. (AKRO)

ATP Life Science Ventures L.P. 13D and 13G filings for Akero Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-06-28
8:56 pm
Sale		 2021-06-21 13D Akero Therapeutics, Inc.
AKRO		 ATP Life Science Ventures L.P. 674,640
1.900%		 -5,164,229decrease
(-88.45%)		 Filing
2020-07-14
5:06 pm
Purchase		 2020-07-10 13D Akero Therapeutics, Inc.
AKRO		 ATP Life Science Ventures L.P. 5,838,869
17.200%		 423,666increase
(+7.82%)		 Filing